Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

822 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Long-term follow-up results of no initial therapy for ocular adnexal MALT lymphoma.
Tanimoto K, Kaneko A, Suzuki S, Sekiguchi N, Maruyama D, Kim SW, Watanabe T, Kobayashi Y, Kagami Y, Maeshima A, Matsuno Y, Tobinai K. Tanimoto K, et al. Among authors: matsuno y. Ann Oncol. 2006 Jan;17(1):135-40. doi: 10.1093/annonc/mdj025. Epub 2005 Oct 19. Ann Oncol. 2006. PMID: 16236754 Free article.
Detection of t(I 1; 18) in MALT-type lymphoma with dual-color fluorescence in situ hybridization and reverse transcriptase-polymerase chain reaction analysis.
Kobayashi Y, Nakata M, Maekawa M, Takahashi M, Fujii H, Matsuno Y, Fujishiro M, Ono H, Saito D, Takenaka T, Hirase N, Nishimura J, Akioka T, Enomoto K, Mikuni C, Hishima T, Fukayama M, Sugano K, Hosoda F, Ohki M, Tobinai K. Kobayashi Y, et al. Among authors: matsuno y. Diagn Mol Pathol. 2001 Dec;10(4):207-13. doi: 10.1097/00019606-200112000-00001. Diagn Mol Pathol. 2001. PMID: 11763310
Factors affecting toxicity, response and progression-free survival in relapsed patients with indolent B-cell lymphoma and mantle cell lymphoma treated with rituximab: a Japanese phase II study.
Igarashi T, Kobayashi Y, Ogura M, Kinoshita T, Ohtsu T, Sasaki Y, Morishima Y, Murate T, Kasai M, Uike N, Taniwaki M, Kano Y, Ohnishi K, Matsuno Y, Nakamura S, Mori S, Ohashi Y, Tobinai K; IDEC-C2B8 Study Group in Japan. Igarashi T, et al. Among authors: matsuno y. Ann Oncol. 2002 Jun;13(6):928-43. doi: 10.1093/annonc/mdf155. Ann Oncol. 2002. PMID: 12123339 Free article. Clinical Trial.
Japanese multicenter phase II and pharmacokinetic study of rituximab in relapsed or refractory patients with aggressive B-cell lymphoma.
Tobinai K, Igarashi T, Itoh K, Kobayashi Y, Taniwaki M, Ogura M, Kinoshita T, Hotta T, Aikawa K, Tsushita K, Hiraoka A, Matsuno Y, Nakamura S, Mori S, Ohashi Y; IDEC-C2B8 Japan Study Group. Tobinai K, et al. Among authors: matsuno y. Ann Oncol. 2004 May;15(5):821-30. doi: 10.1093/annonc/mdh176. Ann Oncol. 2004. PMID: 15111353 Free article. Clinical Trial.
822 results